Hong Kong Diabesity Register
Official title: Establishment of Hong Kong Diabesity Register
Run by Chinese University of Hong Kong · NCT07247409 · Data updated 2026-11-12
This project will collect health data to see how type 2 diabetes with obesity changes over time in adults aged 18–50 who can read Chinese and use a smartphone.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | October 22, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2029 |
| Registry record updated | November 25, 2025 |
| Trial ID | NCT07247409 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–50 with type 2 diabetes and obesity (BMI ≥27.5 kg/m2 or waist ≥80 cm in women/≥90 cm in men) who can read Chinese and use smartphone/web-based tools.
✕Probably not a fit
People with type 1 diabetes, active or recent cancer (less than 5 years disease-free), life expectancy under 12 months, or those unable to read Chinese or use smartphone technology are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants receive a structured baseline assessment by nurses guided by the JADE web portal, including eye and foot exams and blood and urine tests. Key measures collected include BMI, blood pressure, HbA1c, lipid profile, renal and liver function, and urine albumin–creatinine ratio. Patients return at three years for repeat physical and psychological health assessments to document changes over time. The register is observational and does not assign any experimental treatments.
Why it matters
Potential benefit: If successful, the register could help detect complications earlier and inform more personalized care and public-health planning for young adults with diabesity in Hong Kong.
How similar studies have gone: JADE-based registries and other diabetes cohorts in Asia have previously been used to improve risk stratification and care coordination, though the magnitude of benefit varies by program and setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Type 2 diabetes; 2. Obesity reaching action level as defined as body mass index (BMI) 27.5 kg/m2 and/or waist circumference (WC) 80cm in women and 90cm in men; 3. Age between 18 and 50 years; 4. Able to conversate with smartphone technology and web-based program. 5. Able to read Chinese and communicate using Chinese. Exclusion Criteria: 1. Type 1 diabetes; 2. Active malignant disease including those with history of malignant disease less than 5 years of disease-free duration; 3. Life expectancy less than 12 months; 4. Any medical illness or condition as judged by the investigators as ineligible to participate the study.
Where it's running
-
Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Alice Pik Shan Kong, MD
- Email: alicekong@cuhk.edu.hk
- Phone: +852 3505 2648
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hong Kong register and 3-year integrated care program for Chinese adults with diabesity
This program will test whether a 3-year team-based approach (medical therapy, dietitian and psychologist support, e-care with an AI chatbot, biofeedback and peer support) helps Chinese adults aged 18–50 with type 2 diabetes and obesity lose weight and improve physical and mental health.
-
Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia
This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.
-
Ultrasound-guided microwave ablation for benign thyroid nodules
This study tests whether using ultrasound-guided microwave ablation to shrink benign thyroid nodules under local anesthesia is safe and effective, compared with traditional surgery.
-
Romiplostim added to standard ESA therapy in adults on hemodialysis with ESA-resistant anemia
This phase 2 study tests whether adding romiplostim to ongoing ESA treatment is safe and tolerable for adults on dialysis whose anemia does not respond well to ESAs.
-
Metomidate PET-CT vs Usual Care for Primary Aldosteronism
This study tests whether [11C] metomidate PET-CT can help orient treatment for people with primary aldosteronism compared with the usual adrenal venous sampling approach.
-
VR-based sensory stimulation to prevent delirium in ICU patients
This trial tests whether immersive virtual reality sensory stimulation can delay or reduce delirium in adult ICU patients compared with a non-immersive, tablet-based sensory experience.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.